期刊文献+

新疆地区狼疮肾炎患者尿液单核细胞趋化因子1水平及临床意义

The levels of urinary monocyte chemoattractant protein 1 and clinical significance in Xinjiang patients with lupus nephritis
暂未订购
导出
摘要 目的探讨狼疮肾炎(lupus nephritis,LN)患者尿液中单核细胞趋化因子1(monocyte chemoattractant protein 1,MCP-1)的水平及其临床意义。方法采用横断面调查研究分析方法,ELISA法检测33例活动期狼疮肾炎患者和35例缓解期狼疮肾炎患者尿液中MCP-1水平。结果活动期狼疮肾炎患者MCP-1水平[468.0(205~1 990)pg/mg Cr]明显高于缓解期狼疮肾炎患者[131.5(69~734)pg/mg Cr],差异有统计学意义(P=0.000)。活动期狼疮肾炎组患者年龄(25.9±3.7)岁,缓解期狼疮肾炎组患者年龄(29.7±3.5)岁,两组年龄有统计学差异(P<0.05),活动期狼疮肾炎组患者抗ds-DNA抗体阳性率高于缓解期狼疮肾炎组患者(P<0.05)。两组在性别和族别上无统计学差异(P>0.05)。活动期狼疮肾炎组患者尿液中MCP-1水平与24h尿蛋白定量及24h尿白蛋白/肌酐(Urinary albumin-to-creatinine,UACR)呈正相关(r=0.916,P=0.000;r=0.936,P=0.000)。结论活动期狼疮肾炎患者尿液中MCP-1水平升高,对狼疮肾炎的活动性及复发具有可靠稳定的临床诊断意义。需进行前瞻性研究进一步明确其临床意义。 Objective To investigate urinary levels of monocyte chemoattractant protein 1(MCP-1)in Xin-jiang patients with lupus nephritis(LN),and analyze the relationship of MCP-1 with 24-hour proteinuria and 24-hour urinary albumin-to-creatinine ratio(UACR)in active lupus nephritis.Methods A cross-sec-tional cohort analysis was performed.Urinary MCP-1 levels of 33 active lupus nephritis patients and 35 in-active lupus nephritis were measured by ELISA.Results Urinary MCP-1 levels of active lupus nephritis patients were significantly higher than that of inactive lupus nephritis 468.0(205-1 990)pg/mg Cr vs 131.5 (69-734)pg/mg Cr,P=0.000).The mean age of active lupus nephritis was younger than that of inactive lupus nephritis(25.9 ± 3.7 vs 29.7 ± 3.5,P 〈 0.05)and the rate of positive anti-dsDNA antibody was higher in active lupus nephritis (P 〈 0.05).However,there was no difference in gender and ethnicity be-tween the two groups (P 〉 0.05).Urinary MCP-1 was strongly correlated with 24-hour proteinuria and 24-hour UACR (r= 0.916,P=0.000 ;r=0.936,P=0.000).Conclusion Urinary MCP-1 concentration is a good biomarker for the j udgment of lupus nephritis flare and activity.Providing the Longitudinal stud-ies are warranted.
出处 《新疆医科大学学报》 CAS 2013年第10期1447-1450,共4页 Journal of Xinjiang Medical University
基金 新疆维吾尔自治区自然科学基金(2013211A094)
关键词 系统性红斑狼疮 狼疮肾炎 单核细胞趋化因子 1 Systemic lupus erythematosus Lupus nephrits monocyte chemoattractant protein 1
  • 相关文献

参考文献13

  • 1Estes D,Christian CL. The natural history of systemic lupus erythematosus by prospective analysis[J]. Medicine, 1971,50 (2) : 85-95.
  • 2de Zubiria Salgado A, Herrera Diaz C, et al. Lupus nephritis: an overview of recent findings [J].Autoimmune Dis, 2012, (2012) : 849684.
  • 3Chan RW, Lai FM, Li EK, et al. Intrarenal cytokine gene ex- pression in lupus nephritis[J]. Ann Rheum Dis, 2007, 6(3 (7) : 886-892.
  • 4Marks SD,Shah V,Pilkington C,et al. Urinary monocyte che- moattractant protein 1 correlates with disease activity in lupus nephritis[J]. Pediatr Nephrol,2010,25(11) : 2283-2288.
  • 5Brunner HI, Bennett MR, Mina R, et al. Association of nonin- vasively measured renal protein biomarkers with histologie features of lupus nephritis[J]. Arthritis Rheum, 2012,64 (8) : 2687-2697.
  • 6Alzawawy A, Zohary M, Ablordiny M, et al. Estimation of monocyte chemoattractant protein-1 (Mcp-1) level in patients with lupus nephritis[J].Int J Rheum Dis,2009,12(4) : 311-318.
  • 7Hochberg MC. Updating the American College of Rheumatolo gy revised criteria for the classification of systemic lupus cry thematosus[J]. Arthritis Rheum,1997,40(9) : 1725.
  • 8Isenberg DA,Rahman A, Allen E, et al. BILAG 2004. Devel- opment and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus[J]. Rheuma- tology (Oxford) ,2005,44(7) : 902 906.
  • 9Austin HA 3rd, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data[J]. Am J Med,1983,75(3) : 382-391.
  • 10Austin HA,Boumpas DT,Vaughan EM,et al. High risk fea- tures of lupus nephritis: importance of race and clinical and histological factors in 166 patients[J]. Nephrol Dial Trans Plant.1995,10(9), 1620-1628.

二级参考文献18

  • 1Gerli R, Caponi L. Anti-ribosomal P protein antibodies[J]. Autoimmunity, 2005, 38(1):85-92.
  • 2Arnett FC, Reveille JD, Moustopoulos HM, et al. Ribosomal P autoantibodies in systemic lupus erythematosus. Frequencies in different ethnic groups and clinical and immunogenetie asso- ciation[J]. Arthritis Rheum, 1996, 39(11) :1833-1839.
  • 3Isenberg DA, Garton M, Reichlin MW, et al. long-term fol- low-up of autoantibody profiles in black female lupus patients and clinical comparison with Caucasian and Asian patients[J]. Br J Rheumatol, 1997, 136(2) ,229-233.
  • 4Koren E, Schnitz, Reichlin M. Concomitant development of chronic active hepatitis and antibodies to ribosomal P proteins in a patient with systemic lupus erythematosus[J]. Arthritis Rheum, 1993, 36(9):1325-1328.
  • 5Yoshio T, Masuyama JI, Minota S, et al. A close temporal relationship of liver disease to antiribosomal P0 protein anti- bodies and central nervous system disease in patients with sys- temic lupus erythematosus[J]. J Rheumatol, 1998, 25 (4) : 681-688.
  • 6Monova D, Argirova T, Monov S, et al. Antiribosomal P an- tibodies in patients with lupus glomerulonephritis [J]. Clin Nephrol, 2001, 55(5):425-426.
  • 7Haddouk S, Marzouk S, Jallouli M, et aL Clinical and diag- nostic value of ribosomal P autoantibodies in systemic lupus er- ythematosus[J]. Rheumatology (Oxford), 2009, 48 (8) : 953- 957.
  • 8Hochberg MC. Updating the American College of Rheumatol- ogy revised criteria for the classification of systemic lupus ery- thematosus[J]. Arthritis Rheum, 1997, 40(9) : 1725.
  • 9The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes[J]. Arthritis Rheum, 1999,42(4) :599-608.
  • 10Bombardier C, Gladman DD, Urowitz MB, et al. The Com- mittee on Prognosis Studies in SLE. Derivation of the SLE- DAI. A disease activity index for lupus patients[J]. Arthritis Rheum, 1992, 35(6) :630-640.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部